Religare Enterprises Limited has released its Monitoring Agency report for the quarter ending March 31, 2026. The company, which raised ₹1,500 crore through a preferential issue of convertible warrants, has confirmed that all proceeds utilized thus far are in alignment with the objectives outlined in the offer document. The report details the strategic deployment of funds toward key subsidiary investments, debt repayment, and general corporate purposes.
Utilization of Preferential Issue Proceeds
As of the quarter ending March 31, 2026, Religare Enterprises Limited has effectively managed the proceeds from its ₹1,500 crore preferential issue of warrants. The monitoring report confirms that the funds have been directed toward the company’s planned objectives, including investments in its subsidiaries: Care Health Insurance Limited, Religare Broking Limited, and Religare Housing Development Finance Corporation Limited. A portion of the funds has also been successfully allocated toward the repayment of company borrowings and interest obligations.
Strategic Financial Updates
The company provided key insights into its broader financial landscape, noting that while it reported losses over the last three quarters of FY26, it has initiated a significant strategic shift. In February 2026, the Board approved a scheme to demerge its financial services business into Religare Finvest Limited. This reorganization aims to create mirror shareholding across both entities and is currently awaiting necessary regulatory and stakeholder approvals, with a targeted completion date by Q1 FY28.
Operational Status and Market Context
The monitoring agency noted no deviations in the implementation of the project objects. Regarding general corporate purposes, the company utilized ₹4.17 crore during the quarter for operational expenses, including salaries and administrative vendor payments. Furthermore, the report highlighted that the current market price of the company’s shares is ₹224, which is lower than the overall issue price of ₹235 per warrant, but exceeds the pending call amount of ₹176.25 for the remaining 29,929,076 warrants.
Source: BSE
